Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Froschermaier

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Urological Research|January 1, 1997
The antiandrogen withdrawal syndromeM P Wirth, S E Froschermaier
Der Urologe. Ausg. A|January 1, 1997
[Significance of 5-alpha-reductase inhibitors in therapy of benign prostatic hyperplasia with mild to modern symptoms]M P Wirth, C Helke, S E Froschermaier
Urology|April 1, 1996
Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinomaS E Froschermaier, C P Pilarsky, M P Wirth
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|August 14, 1998
[Screening in prostate carcinoma]M P Wirth, T Spiegel, S E Froschermaier, et al.
Urologia Internationalis|February 6, 1999
Enhanced external counterpulsation as a new treatment modality for patients with erectile dysfunctionS E Froschermaier, D Werner, S Leike, et al.
The Prostate|July 9, 1998
Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancerC P Pilarsky, U Schmidt, C Eissrich, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Urological Research|January 1, 1997
The antiandrogen withdrawal syndromeM P Wirth, S E Froschermaier
Der Urologe. Ausg. A|January 1, 1997
[Significance of 5-alpha-reductase inhibitors in therapy of benign prostatic hyperplasia with mild to modern symptoms]M P Wirth, C Helke, S E Froschermaier
Urology|April 1, 1996
Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinomaS E Froschermaier, C P Pilarsky, M P Wirth
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|August 14, 1998
[Screening in prostate carcinoma]M P Wirth, T Spiegel, S E Froschermaier, et al.
Urologia Internationalis|February 6, 1999
Enhanced external counterpulsation as a new treatment modality for patients with erectile dysfunctionS E Froschermaier, D Werner, S Leike, et al.
The Prostate|July 9, 1998
Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancerC P Pilarsky, U Schmidt, C Eissrich, et al.
Pageof 1